Biodesix Inc (NAS:BDSX)
$ 1.45 0.04 (2.84%) Market Cap: 166.29 Mil Enterprise Value: 215.98 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Q4 2022 Biodesix Inc Earnings Call Transcript

Mar 06, 2023 / 01:00PM GMT
Release Date Price: $1.8 (-10.00%)
Operator

Good day and thank you for standing by. Welcome to the Biodesix fourth-quarter and year-end 2022 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to turn the conference over to Chris Brinzey. Please go ahead.

Chris Brinzey
ICR Westwicke - IR

Thank you, operator, and good morning, everyone. Thank you for joining us today for a discussion of Biodesix's fourth quarter and year ended 2022 business highlights and financial results. Leading the call today will be Scott Hutton, Chief Executive Officer, who will be joined by Robin Harper Cowie, Chief Financial Officer.

After the prepared remarks, we'll open the call for Q&A. An audio recording and webcast replay of today's conference call will also be available online as detailed in the press release announcement for this call.

Today, we issued a press release announcing our business highlights and financial results for the fourth quarter and year ended 2022. A copy of the release can be found on the Investor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot